Review



human il 12 p70 duosettm elisa development systems  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems human il 12 p70 duosettm elisa development systems
    Human Il 12 P70 Duosettm Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 84 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/10__1158_slash_2326___6066__cir___25___1399-112-16-26
    Average 95 stars, based on 84 article reviews
    human il 12 p70 duosettm elisa development systems - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics.
    Article Snippet: Togetherwith aAPC, 5 ng/ml human IL-12 p70 (R&D System) was added.

    Article Title: Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omics
    Article Snippet: Together with aAPC, 5 ng/ml human IL-12 p70 (R&D System) was added.

    Article Title: MHC molecule-binding tumor-associated peptides
    Article Snippet: Additionally, 5 ng/mL human IL-12 p70 (R&D Systems) were added.

    Article Title: MHC molecule-binding tumor-associated peptides
    Article Snippet: 5 ng/mL human IL-12 p70 (R&D Systems, USA) were added together with microspheres.

    Enzyme-linked Immunosorbent Assay:

    Article Title: EFFECTS OF ORAL ALFACALCIDOL ON MATURATION OF DENDRITIC CELLS IN GRAVES’ DISEASE PATIENTS: A DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL
    Article Snippet: .. Measurement of cytokine levels (IL-12 and IL-10) was done using Human IL-12 p70 (Quantikine HS ELISA Kit - R&D Systems kit) and Human IL-10 (Quantikine ELISA Kit - R&D Systems). ..

    Article Title: IL-12 and IL-23 Production in Toxoplasma gondii- or LPS-Treated Jurkat T Cells via PI3K and MAPK Signaling Pathways
    Article Snippet: .. Human IL-12 p70 and IL-23 were detected using an ELISA kit according to the manufacturer’s instructions (R&D Systems, Inc., Minneapolis, Minnesota, USA). ..

    Article Title: Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12
    Article Snippet: The protein bands were scanned with an Image Lab scanner (BioRad). .. Human IL-12 p70 and anti-PD-1 Ab analysis The human IL-12 p70 Quantikine ELISA Kit was purchased from R&D Systems (Minneapolis, MN, USA). ..

    Article Title: Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.
    Article Snippet: Intracellular staining or granyzme B (clone GB11), or TCF1 (clone S33-966) was performed on single cell suspensions of tumors using BD Cytofix/Cytoperm Plus Kit (Cat No.555028, BD Biosciences) according to the manufacturer’s instructions. .. ELISA ELISA was performed using kits to detect mouse IFNβ (Cat No. 42400, PBL ASSAY SCIENCE), human IFNβ (Cat No. 41410, PBL ASSAY SCIENCE) human IL-12 p70 (Cat No. D1200, R&D Systems) and human TNFα (Cat No. 430204, Biolegend). .. Flow cytometric analysis was performed on BD FACSymphony and analyzed using FlowJo software (version 10.7.1, Tree Star).



    Similar Products

    95
    R&D Systems human il 12 p70 duosettm elisa development systems
    Human Il 12 P70 Duosettm Elisa Development Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/10__1158_slash_2326___6066__cir___25___1399-112-16-26
    Average 95 stars, based on 1 article reviews
    human il 12 p70 duosettm elisa development systems - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology il12p70
    Il12p70, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Uncoated+Human+IL-12%2FP70+(Interleukin+12%2FP70)+ELISA+Kit/pm41269243-98-22-39
    Average 94 stars, based on 1 article reviews
    il12p70 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    R&D Systems human il 12 p70 elisa kit
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Human Il 12 P70 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Quantikine+ELISA+Kit/bio_rxiv__64898__2026__03__30__715452-195-7-12
    Average 95 stars, based on 1 article reviews
    human il 12 p70 elisa kit - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems rnd systems 442
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Rnd Systems 442, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/pm41889175-194-19-19
    Average 95 stars, based on 1 article reviews
    rnd systems 442 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems human il 12p70
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Human Il 12p70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/pm41889175-198-21-23
    Average 95 stars, based on 1 article reviews
    human il 12p70 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    95
    R&D Systems human il 12p70 elisa
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Human Il 12p70 Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+DuoSet+ELISA/pm41889175-194-15-19
    Average 95 stars, based on 1 article reviews
    human il 12p70 elisa - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    92
    Miltenyi Biotec anti il 12p70 mab
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Anti Il 12p70 Mab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/IL-12+(p70)+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__03__17__712383-203-9-12
    Average 92 stars, based on 1 article reviews
    anti il 12p70 mab - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    94
    R&D Systems resource source identifier antibodies human il 12 p70 antibody
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Resource Source Identifier Antibodies Human Il 12 P70 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Antibody/pm41818238-53-2-14
    Average 94 stars, based on 1 article reviews
    resource source identifier antibodies human il 12 p70 antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems mab219
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Mab219, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Antibody/pm41818238-53-18-31
    Average 94 stars, based on 1 article reviews
    mab219 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems anti human il12 p70
    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations <t>for</t> <t>IL-12</t> secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Anti Human Il12 P70, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+il+12+p70/Human+IL-12+p70+Antibody/pm41772660-46-25-29
    Average 94 stars, based on 1 article reviews
    anti human il12 p70 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations for IL-12 secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: bioRxiv

    Article Title: BLAST: A blue light-assisted secretion toolkit tunable by reversible protein-protein interactions

    doi: 10.64898/2026.03.30.715452

    Figure Lengend Snippet: Secretion of therapeutic proteins with a-BLAST and d-BLAST. (a) The human preproinsulin (preproINS) construct contains a signal peptide, B-chain (yellow), C-peptide (dark gray), and A-chain (yellow), with engineered Furin cleavage sites flanking the C-peptide for maturation. To facilitate efficient processing within the Golgi apparatus, Furin protease was co-transfected with the BLAST modules. (b) Kinetic profiling of light-induced insulin secretion. Summary graphs of secreted C-peptide levels, quantified by ELISA, as a proxy for insulin secretion from a-BLAST (left) and d-BLAST (right). Both systems exhibited significant, time-dependent insulin release starting from 2 h of illumination (8.2-fold for a-BLAST, 8.4-fold for d-BLAST), reaching maximal induction at 24 h (13.8-fold for a-BLAST, 19.3-fold for d-BLAST). (c) Plasmid configurations for IL-12 secretion. Schematic of the heterodimeric cytokine IL-12-a-BLAST (left) and d-BLAST-IL-12 (right) constructs. (d) Kinetic profiling of light-induced IL-12 secretion. Summary graphs showing IL-12 secretion levels measured by ELISA. Significant secretion was observed starting at 3 h for a-BLAST (2.5-fold) and 2 h for d-BLAST (2.2-fold). At the 24 h time point, d-BLAST (4.7-fold) demonstrated a slightly higher dynamic range compared to a-BLAST (4.5-fold). Open circles represent individual measurements from three biologically independent samples. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (ns = not significant, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Similarly, IL-12 secretion was measured using a Human IL-12 p70 ELISA Kit (R&D Systems; Catalog #D1200) according to the manufacturer’s instructions.

    Techniques: Construct, Transfection, Enzyme-linked Immunosorbent Assay, Plasmid Preparation

    Functional validation of optogenetically secreted IL-12 using a reporter cell assay. (a) Schematic of the experimental workflow for bioactivity validation. The protocol spans 5 days. HEK293T cells transfected with BLAST-IL-12 were subjected to dark or blue light conditions for 24 h (Day 3). On Day 4, the conditioned media containing secreted IL-12 was harvested and transferred to HEK-Blue™ IL-12 reporter cells (seeded on Day 3). After a 24 h incubation to allow for signal transduction, SEAP activity was quantified (Day 5). (b) Plasmid configurations. Schematics of the a-BLAST-IL-12 (upper) and d-BLAST-IL-12 (lower) constructs used for the assay. (c) Illustration of the JAK-STAT signaling pathway in the reporter cells. Binding of secreted IL-12 to the IL-12 receptor complex activates Tyk2/JAK2, leading to STAT4 phosphorylation. Phosphorylated STAT4 dimerizes and translocates to the nucleus to induce SEAP expression. (d) Summary graph of SEAP activity induced by the conditioned media. The results confirm that both systems secrete biologically active IL-12 upon blue light stimulation, exhibiting robust fold changes (12.4-fold for a-BLAST and 11.3-fold for d-BLAST) compared to the dark control. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (**** P < 0.0001).

    Journal: bioRxiv

    Article Title: BLAST: A blue light-assisted secretion toolkit tunable by reversible protein-protein interactions

    doi: 10.64898/2026.03.30.715452

    Figure Lengend Snippet: Functional validation of optogenetically secreted IL-12 using a reporter cell assay. (a) Schematic of the experimental workflow for bioactivity validation. The protocol spans 5 days. HEK293T cells transfected with BLAST-IL-12 were subjected to dark or blue light conditions for 24 h (Day 3). On Day 4, the conditioned media containing secreted IL-12 was harvested and transferred to HEK-Blue™ IL-12 reporter cells (seeded on Day 3). After a 24 h incubation to allow for signal transduction, SEAP activity was quantified (Day 5). (b) Plasmid configurations. Schematics of the a-BLAST-IL-12 (upper) and d-BLAST-IL-12 (lower) constructs used for the assay. (c) Illustration of the JAK-STAT signaling pathway in the reporter cells. Binding of secreted IL-12 to the IL-12 receptor complex activates Tyk2/JAK2, leading to STAT4 phosphorylation. Phosphorylated STAT4 dimerizes and translocates to the nucleus to induce SEAP expression. (d) Summary graph of SEAP activity induced by the conditioned media. The results confirm that both systems secrete biologically active IL-12 upon blue light stimulation, exhibiting robust fold changes (12.4-fold for a-BLAST and 11.3-fold for d-BLAST) compared to the dark control. Data are presented as means ± S.D. Statistical significance was assessed using one-way ANOVA followed by Tukey’s multiple comparisons test (**** P < 0.0001).

    Article Snippet: Similarly, IL-12 secretion was measured using a Human IL-12 p70 ELISA Kit (R&D Systems; Catalog #D1200) according to the manufacturer’s instructions.

    Techniques: Functional Assay, Biomarker Discovery, Transfection, Incubation, Transduction, Activity Assay, Plasmid Preparation, Construct, Binding Assay, Phospho-proteomics, Expressing, Control